← back to search

Rawlings Datir

University College London · GB
Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies, and HIV Research and Treatment.
h-index
18
citations
5,806
works
33
NIH funding
primary concept
Medicine
email

Recent publications

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
Nature 2022cited by 6position: middledoi
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2022cited by 3position: middledoi
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Nature 2021cited by 1,416position: middledoi
SARS-CoV-2 evolution during treatment of chronic infection
Nature 2021cited by 1,077position: middledoi
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2021cited by 713position: middledoi
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Cell Reports 2021cited by 448position: middledoi
Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I
The Journal of Infectious Diseases 2019cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2019–2019)Soo‐Yon Rhee · KU Leuven1 papers (2019–2019) · 1 papers (2019–2019)Deenan Pillay · University of Oxford1 papers (2019–2019) · 1 papers (2019–2019)John Gregson · University of London1 papers (2019–2019)Ravindra K. Gupta · University of Cambridge1 papers (2019–2019)